1. P613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANISM FOLLOWING BTKI THERAPY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA. (23rd June 2022) Authors: Kennedy, E.; Mitchell, S.; Burley, T. A.; Liloglou, T.; Johnston, R.; Ashworth, I.; Bak-Blaz, D.; Chamberlain, K.; Ladikou, E.; Mackay, S.; Pepper, C.; Pepper, A. G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1788: LOW EXPRESSION OF C-TYPE LECTIN-LIKE MOLECULE-1 AND REDUCED OXIDATIVE STRESS DEFINE A SUBSET OF ACUTE MYELOID LEUKAEMIA CELLS WITH 'STEM-LIKE' PROPERTIES. (23rd June 2022) Authors: Sharp, K.; Ladikou, E.; Burley, T.; Kennedy, E.; Pepper, A.; Pepper, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗